skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Diagnosis of biliary atresia with radionuclide hepatobiliary imaging

Journal Article · · Radiology; (United States)

Sixteen patients with biliary atresia and 11 patients with neonatal hepatitis were studied preoperatively with either Tc99m-diethyl-IDA or Tc99m-diisopropyl-IDA. Two parameters were evaluated: hepatocyte clearance and time to appearance of radioactivity in the intestine. Two observers, using a visual grading system of 1 to 4, gave the 16 patients with biliary atresia a hepatocyte clearance grade of 1.7 +/- 0.6 (mean +/- SD); intestinal radioactivity was not seen through 24 hours. The hepatocyte clearance grade of the 11 patients with neonatal hepatitis was 2.1 +/- 0.9 (mean +/- SD) (p>0.05); intestinal radioactivity was seen in nine of 11 patients (p<0.001). Using both parameters, 91% of the patients were classified correctly, 4% were misclassified, and 6% were classified as indeterminate; sensitivity and specificity for biliary atresia were 97% and 82%, respectively. Radionuclide imaging with the newer technetium-99m-labeled hepatobiliary radiopharmaceuticals appears promising for the non-invasive diagnosis of biliary atresia.

Research Organization:
Univ. of Colorado Health Sciences Center, Denver
OSTI ID:
6085967
Journal Information:
Radiology; (United States), Vol. 146:2
Country of Publication:
United States
Language:
English